LBA95 Neoadjuvant immunotherapy in locally advanced clear cell renal cell carcinoma at risk for recurrence or distant metastases: The randomized phase II NESCIO trial
F. Burgers, A. de Ruijter, N.M. Graafland, Maurits van Montfoort, Marta López‐Yurda, Pieter van Hagen, Patricia Zondervan, Sybren P. Rynja, Marit J. Yska, An F.C. Ruiter, Astrid M. van Leeuwen, R. de Vries, Brunolf W. Lagerveld, Daniël J. Vis, S. Wilgenhof, H.V. van Thienen, C.U. Blank, Koen van der Mijn, A. Bex, J.B.A.G. Haanen
Topics & Concepts
MedicineOncologyInternal medicineImmunotherapyClear cell renal cell carcinomaRenal cell carcinomaPhases of clinical researchRandomized controlled trialClear cellNeoadjuvant therapyKidney cancerClinical trialChemotherapyCarcinomaCellMEDLINEKidney diseaseRenal cell carcinoma treatmentRenal and related cancersImmunotherapy and Immune Responses